BioHealth News

BISNOW/MCEDC: With Multimillion-Dollar Acquisitions And Developments, Life Sciences To Boom In Montgomery County, Maryland

BISNOW/MCEDC: With Multimillion-Dollar Acquisitions And Developments, Life Sciences To Boom In Montgomery County, Maryland

The life sciences industry is seeing tremendous growth in Maryland, particularly in the D.C. suburb of Montgomery County. With nearly $6B invested in life sciences…

Read More
Precigen Receives FDA Clearance of IND to Initiate Phase 2 Study

Precigen Receives FDA Clearance of IND to Initiate Phase 2 Study

Precigen Receives FDA Clearance of IND to Initiate Phase 2 Study of PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy in Combination with Pembrolizumab to Treat Patients with…

Read More
TEDCO Announces Investment into Pathotrak

TEDCO Announces Investment into Pathotrak

COLUMBIA, Md. (May 23, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced a Venture Funds investment of $300,000 into Pathotrak, a biotechnology…

Read More
BioHealth Innovation Welcomes Entrepreneur-in-Residence  Claire Leurent, Ph.D. MBA at NIH’s SEED Program

BioHealth Innovation Welcomes Entrepreneur-in-Residence Claire Leurent, Ph.D. MBA at NIH’s SEED Program

Entrepreneurs-in-Residence (EIR) Team Continues Growth With National Institutes of Health (NIH) ROCKVILLE, MARYLAND, May 30, 2023 – BioHealth Innovation Inc. (BHI) proudly welcomes Claire Leurent,…

Read More
Technical.ly: Meet the Maryland innovators behind the state’s best 2023 inventions

Technical.ly: Meet the Maryland innovators behind the state’s best 2023 inventions

What do you get when you combine a networking happy hour for STEM researchers, an engaging expert panel discussion and a host of exciting…

Read More
Emergent BioSolutions Announces the Execution of Contract Option to Deliver ACAM2000 into the Strategic National Stockpile

Emergent BioSolutions Announces the Execution of Contract Option to Deliver ACAM2000 into the Strategic National Stockpile

On May 26, 2023, Emergent BioSolutions Inc. (including its wholly-owned subsidiaries, “Emergent”), through its wholly-owned subsidiary, Emergent Product Development Gaithersburg Inc., received a contract…

Read More
ABL awarded seven-year NIH contract for continued support in HIV prevention products

ABL awarded seven-year NIH contract for continued support in HIV prevention products

Rockville, MD, United States, May 23, 2023 – Advanced BioScience Laboratories (ABL), a global Contract Development and Manufacturing Organization (CDMO) for biotherapies,oncolytics and viral…

Read More
Hememics Biotechnologies, Inc. Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth

Hememics Biotechnologies, Inc. Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth

GAITHERSBURG, Md., May 25, 2023 /PRNewswire/ -- Hememics Biotechnologies, Inc., developer of first-in-class, handheld, multiplexed biosensor platform that can test antibodies, antigens and molecular targets simultaneously, announced…

Read More
Gaithersburg’s Adaptive Phage Therapeutics Enters Collaboration and License Agreement with Hebrew University of Jerusalem and Hadassah Medical Center

Gaithersburg’s Adaptive Phage Therapeutics Enters Collaboration and License Agreement with Hebrew University of Jerusalem and Hadassah Medical Center

GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections, is pleased to announce…

Read More
Rockville’s REGENXBIO Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RGX-121 Gene Therapy for Hunter Syndrome

Rockville’s REGENXBIO Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RGX-121 Gene Therapy for Hunter Syndrome

ROCKVILLE, Md., May 23, 2023 /PRNewswire/ --REGENXBIO Inc. (Nasdaq: RGNX) today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT)…

Read More
Maryland Stem Cell Research Commission Announces Over $14 Million in Awards to Accelerate Cures

Maryland Stem Cell Research Commission Announces Over $14 Million in Awards to Accelerate Cures

Commission also issues Request for Applications for Four Funding Programs for July 13, 2023, Deadline COLUMBIA, Md. (May 9, 2023) —The Maryland Stem Cell Research…

Read More
TEDCO Announces Investment into CarrTech Corp.

TEDCO Announces Investment into CarrTech Corp.

Maryland medical device company supports patients and medical professionals through safer needle filtration device COLUMBIA, Md. (May 22, 2023) – TEDCO, Maryland’s economic engine…

Read More
JLL Life Sciences Observations Suburban Maryland Q1 2023

JLL Life Sciences Observations Suburban Maryland Q1 2023

Summary and analysis of Maryland's suburban current economic and office real estate market conditions. Click here to read the entire report.

Read More
Harsha Rajasimha, PhD, founder and CEO of Jeeva Informatics discusses current challenges leading to clinical trial delays, such as the “valley of death.”

Harsha Rajasimha, PhD, founder and CEO of Jeeva Informatics discusses current challenges leading to clinical trial delays, such as the “valley of death.”

Pharmacy Times® interviewed Harsha Rajasimha, PhD, founder and CEO of Jeeva Informatics, on the potential to accelerate patient recruitment and solve clinical trial delays. Currently,…

Read More
TEDCO Announces SSBCI Investment into N5 Sensors

TEDCO Announces SSBCI Investment into N5 Sensors

Maryland-based business protecting individuals and businesses from environmental hazards through the use of its innovative sensor technology COLUMBIA, Md. (May 22, 2023) – TEDCO, Maryland’s…

Read More